Official UK procurement notice
Stem Cell and Immunotherapy Services
Authority: The Newcastle Upon Tyne Hospitals NHS Foundation Trust (Central government)
What is being bought
Published requirement descriptionStem Cell and Immunotherapy Services
CPV: Blood-transfusion supplies
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 19 Jun 2026, 15:04 BST
- Last source update
- 19 Jun 2026, 15:04 BST
- FTS notice number
2026/S 000-058186- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06b961Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.
Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. Representations by providers must be made to The Newcastle upon Tyne Hospitals NHS Foundation Trust at the following email address: [email protected] Details of the award decision-makers: The decision to award was made by an MDT consisting of representatives from Finance, Clinical Board and Procurement. Declarations of Interest were sought from the members of the MDT prior to consideration of contract award. No declarations of interest were declared. The provider was assessed against 5 key criteria: Quality and Innovation; Value; Integration, collaboration, and service sustainability; Improving access, reducing inequalities, and facilitating choice; and social value. Each criterion was assessed on a pass/fail basis, considering whether they have currently satisfied the criteria under the previous contract and whether they would likely satisfy the criteria under the previous contract and whether they would likely satisfy the proposed contract to a sufficient standard. The provider achieved a pass score against all criteria.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| NHS BLOOD AND TRANSPLANT (NHSBT)SME | — | — | Awarded |
Contracts
Contract 058186-2026-1 · NHS BLOOD AND TRANSPLANT (NHSBT)SME
- Signed
- 19 Jun 2026
- Value
- —
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | £284,201 – £284,201 |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- NHS BLOOD AND TRANSPLANT (NHSBT)Awarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.